We are live on ! Find out more
AB

Amalgamated Bank Portfolio holdings

AUM $14.5B
1-Year Est. Return 44.3%
This Fund
S&P 500
This Quarter Est. Return
+11.16%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$13.5B
AUM Growth
+$1.71B
Cap. Flow
+$608M
Cap. Flow %
4.49%
Top 10 Hldgs %
22.89%
Holding
2,217
New
53
Increased
719
Reduced
1,379
Closed
56

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$89.7M
2
AAPL icon
Apple
AAPL
+$83.9M
3
AMZN icon
Amazon
AMZN
+$58.5M
4
META icon
Meta Platforms (Facebook)
META
+$31.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$29.5M

Sector Composition

Rank Sector Weight
1 Technology 24.15%
2 Healthcare 13.08%
3 Financials 13%
4 Consumer Discretionary 12.33%
5 Industrials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VLDR
2101
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$62K ﹤0.01%
13,317
-359
-3% -$2.1K
PGEN icon
2102
Precigen
PGEN
$1.93B
$60K ﹤0.01%
16,182
-457
-3% -$1.97K
AKBA icon
2103
Akebia Therapeutics
AKBA
$343M
$59K ﹤0.01%
26,073
+1,040
+4% +$2.84K
TTI icon
2104
TETRA Technologies
TTI
$1.14B
$58K ﹤0.01%
20,359
-585
-3% -$1.8K
KOPN icon
2105
Kopin
KOPN
$687M
$56K ﹤0.01%
13,701
-377
-3% -$1.92K
EGIO
2106
DELISTED
Edgio, Inc. Common Stock
EGIO
$56K ﹤0.01%
407
-14
-3% -$1.66K
CLVS
2107
DELISTED
Clovis Oncology, Inc.
CLVS
$54K ﹤0.01%
19,843
-193
-1% -$713
LITS
2108
Lite Strategy Inc
LITS
$33.2M
$51K ﹤0.01%
957
-26
-3% -$1.45K
BDSI
2109
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$51K ﹤0.01%
16,443
-453
-3% -$1.52K
CTMX icon
2110
CytomX Therapeutics
CTMX
$708M
$48K ﹤0.01%
11,002
-384
-3% -$2.25K
GERN icon
2111
Geron
GERN
$949M
$48K ﹤0.01%
39,504
-1,096
-3% -$1.57K
APPH
2112
DELISTED
AppHarvest, Inc. Common Stock
APPH
$47K ﹤0.01%
12,200
-302
-2% -$1.61K
TRUE
2113
DELISTED
TrueCar
TRUE
$42K ﹤0.01%
12,428
-633
-5% -$2.41K
LXRX icon
2114
Lexicon Pharmaceuticals
LXRX
$991M
$41K ﹤0.01%
10,304
-149
-1% -$724
LAB icon
2115
Standard BioTools
LAB
$303M
$40K ﹤0.01%
10,249
-311
-3% -$1.46K
LCTX icon
2116
Lineage Cell Therapeutics
LCTX
$257M
$40K ﹤0.01%
16,306
-237
-1% -$555
RNAC icon
2117
Cartesian Therapeutics
RNAC
$229M
$40K ﹤0.01%
411
-7
-2% -$753
TCRT icon
2118
Alaunos Therapeutics
TCRT
$4.71M
$40K ﹤0.01%
247
-7
-3% -$1.54K
EPZM
2119
DELISTED
Epizyme, Inc
EPZM
$40K ﹤0.01%
16,058
-230
-1% -$904
DRRX
2120
DELISTED
DURECT Corp
DRRX
$39K ﹤0.01%
3,994
-140
-3% -$1.55K
TOON icon
2121
Kartoon Studios
TOON
$34.9M
$39K ﹤0.01%
3,675
-125
-3% -$1.63K
WTI icon
2122
W&T Offshore
WTI
$492M
$39K ﹤0.01%
12,219
-417
-3% -$1.61K
NMTR
2123
DELISTED
9 Meters Biopharma
NMTR
$39K ﹤0.01%
1,987
-36
-2% -$805
AUD
2124
DELISTED
Audacy, Inc.
AUD
$39K ﹤0.01%
15,360
-524
-3% -$1.61K
ASXC
2125
DELISTED
Asensus Surgical, Inc.
ASXC
$38K ﹤0.01%
33,804
-1,167
-3% -$1.8K

Similar funds

Amalgamated Bank's Q4 2021 Portfolio in Review

As of Q4 2021, Amalgamated Bank held 2,217 positions worth $13.5B, up 14% from $11.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Amalgamated Bank deployed $608M of net new capital in Q4 2021, opening 53 new positions and adding to 719 existing holdings. Its largest new stake was IHS Markit Ltd. Common Shares: 104,903 shares worth $13.9M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Signature Bank, an estimated $8.19M trimmed.

  • Amalgamated Bank's largest Q4 2021 buy was IHS Markit Ltd. Common Shares: 104,903 shares worth $13.9M.
  • Amalgamated Bank added most to Microsoft in Q4 2021, an estimated $89.7M increase.
  • Amalgamated Bank's biggest Q4 2021 reduction was Signature Bank, cutting an estimated $8.19M.
  • Amalgamated Bank fully exited Kansas City Southern in Q4 2021, selling an estimated $7.08M.
  • Amalgamated Bank's ten largest holdings make up 23% of its $13.5B portfolio in Q4 2021.
  • Amalgamated Bank opened 53 new positions and closed 56 in Q4 2021.
  • Amalgamated Bank's portfolio value rose 14% quarter-over-quarter to $13.5B.

Based on Amalgamated Bank's 13F filing for Q4 2021, filed 15 Feb 2022.